Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to fight Cancer-Related weight loss with exercise and diet

NCT ID NCT05731076

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This clinical trial tests a 12-week self-management program that combines personalized exercise and nutrition counseling for lung cancer patients experiencing cachexia (unintended weight loss). The study involves 104 participants who will either receive the program or standard care. The goal is to see if the program improves nutritional status and is feasible for patients to follow at home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
self-management support program (exercise and nutrition counseling)
What this could lead to
If successful, this program could help lung cancer patients with cachexia maintain or improve their nutritional status and quality of life.
What could go wrong
This is a small, early-stage trial with only 104 participants, so results may not apply to all patients. The program relies on patient adherence, which can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 104 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosed lung cancer(ICD-10 code: C33-C34) 2. Body weight loss: body weight loss 2% before recruitment 2 months or body weight loss 5% before recruitment 6months. 3. Physician judged may do home exercise without supervisor. 4. Has smart phone and agree to use exercise associated application. 5. Agree to wear Xioami smart band as long as passible. 6. Conscious clear and communication. 7. Eastern Cooperative Oncology Group (ECOG) 0-1. Exclusion Criteria: 1. Participants with cardiovascular disease can't exercise without supervisor. 2. Diabetes Mellitus with blood sugar poor control. 3. Chronic obstructive pulmonary disease with dyspnea on exertion. 4. Platelets \< 50000mm3 due to disease or treatment. 5. Hemoglobin \<10mg/dl. 6. Recently stumble, severe pain, cognitive and behavior change. 7. Suspect or diagnosed brain metastasis. 8. Suspect or diagnosed bone metastasis. 9. Receive Nasogastric tube feeding or parenteral nutrition. 10. Physician judged can't do home exercise.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cachexia-anorexia syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Changhua Christian Hospital

    Changhua, Changhua, 51052, Taiwan

  • Taipei Veterans General Hospital

    Taipei, Taipei, 11219, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.